Gilead Sciences, Inc.
(NASDAQ : GILD)

( )
GILD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.71%203.211.3%$436.19m
BIIBBiogen Inc.
0.73%227.721.3%$386.27m
GILDGilead Sciences, Inc.
0.08%65.350.9%$368.51m
CELGCelgene Corporation
0.02%100.971.3%$353.70m
ILMNIllumina, Inc.
-0.80%309.673.5%$257.96m
REGNRegeneron Pharmaceuticals, Inc.
-1.46%299.402.6%$220.44m
EXASExact Sciences Corporation
-2.17%97.5824.1%$205.36m
ALXNAlexion Pharmaceuticals, Inc.
-5.06%99.512.0%$180.57m
VRTXVertex Pharmaceuticals Incorporated
-0.03%176.091.9%$177.48m
AAgilent Technologies, Inc.
-0.65%75.261.6%$148.26m
SRPTSarepta Therapeutics, Inc.
-1.49%86.7414.6%$140.12m
BMRNBioMarin Pharmaceutical Inc.
-0.83%67.944.3%$95.23m
ALDRAlder Biopharmaceuticals, Inc.
-0.05%18.8710.2%$90.77m
SGENSeattle Genetics, Inc.
0.58%83.866.2%$87.50m
NKTRNektar Therapeutics
1.42%17.545.5%$85.01m

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.